A detailed history of Viawealth, LLC transactions in Novartis Ag stock. As of the latest transaction made, Viawealth, LLC holds 3,203 shares of NVS stock, worth $334,008. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,203
Previous 3,203 -0.0%
Holding current value
$334,008
Previous $341 Million 8.04%
% of portfolio
0.21%
Previous 0.21%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$92.57 - $107.37 $17,125 - $19,863
185 Added 6.13%
3,203 $341 Million
Q4 2022

Feb 13, 2023

BUY
$75.55 - $92.52 $228,009 - $279,225
3,018 New
3,018 $271 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Viawealth, LLC Portfolio

Follow Viawealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viawealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Viawealth, LLC with notifications on news.